All Stories

  1. Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial

    Article • Annals of Neurology, October 2018, Wiley

    Prof Patrick Vermersch

  2. A comparison of multiple sclerosis disease activity after discontinuation of fingolimod and placebo

    Article • Multiple Sclerosis Journal - Experimental Translational and Clinical, September 2017, SAGE Publications

    Prof Patrick Vermersch

  3. Conclusions: Calls to action for improving the life of MS patients and their families

    Article • Multiple Sclerosis Journal, July 2016, SAGE Publications

    Prof Patrick Vermersch

  4. The clinical perspective: How to personalise treatment in MS and how may biomarkers including imaging contribute to this?

    Article • Multiple Sclerosis Journal, July 2016, SAGE Publications

    Prof Patrick Vermersch

  5. Introduction: Do we need multi-stakeholder colloquia in MS?

    Article • Multiple Sclerosis Journal, July 2016, SAGE Publications

    Prof Patrick Vermersch

  6. MS treatment

    Article • Multiple Sclerosis Journal, July 2016, SAGE Publications

    Prof Patrick Vermersch

  7. Measuring treatment satisfaction in MS: Is the Treatment Satisfaction Questionnaire for Medication fit for purpose?

    Article • Multiple Sclerosis Journal, July 2016, SAGE Publications

    Prof Patrick Vermersch

  8. Advances in the management of MS symptoms: recently proposed clinical management algorithms

    Article • Neurodegenerative Disease Management, December 2015, Future Medicine

    Prof Patrick Vermersch